Stifel Maintains Buy on Compugen, Raises Price Target to $4
Benzinga Newsdesk 2 years ago
NewsPrice TargetAnalyst Ratings
Stifel analyst Stephen Willey maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from $3 to $4.
Stifel analyst Stephen Willey maintains Compugen (NASDAQ:CGEN) with a Buy and raises the price target from $3 to $4.